Crossmark

Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients

Crossref DOI link: https://doi.org/10.1007/s15010-018-1258-6

Published Online: 2018-12-05

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mazzola, Giovanni

Adamoli, Lucia

Calvaruso, Vincenza

Macaluso, Fabio Salvatore https://orcid.org/0000-0001-5128-3846
Colletti, Pietro

Mazzola, Sergio

Cervo, Adriana

Trizzino, Marcello

Di Lorenzo, Francesco

Iaria, Chiara

Prestileo, Tullio

Orlando, Ambrogio

Di Marco, Vito

Cascio, Antonio
License Information

Text and Data Mining valid from 2018-12-05
More Information

Article History

Received: 12 August 2018

Accepted: 27 November 2018

First Online: 5 December 2018

Compliance with ethical standards

:

: On behalf of all authors, the corresponding author states that there is no conflict of interest.

Document is current

Any future updates will be listed below